Oncogenic PI3K mutations are as common as<i>AKT1</i>and<i>SMO</i>mutations in meningioma

Malak Abedalthagafi(Tufts University), Sandro Santagata(Harvard University), Ryan Brewster(King Fahd Medical City), Keith L. Ligon(Brigham and Women's Hospital), Marc Listewnik(King Fahd Medical City), Priscilla K. Brastianos(Massachusetts General Hospital), Patrick Y. Wen(Dana-Farber Cancer Institute), Shakti Ramkissoon(Foundation Medicine (United States)), Parker Merrill(King Fahd Medical City), Ossama Al‐Mefty(King Faisal Specialist Hospital & Research Centre), Azra H. Ligon(Brigham and Women's Hospital), Rameen Beroukhim(Broad Institute), Rebecca D. Folkerth(Allen Institute for Brain Science), Wenya Linda Bi(Broad Institute), Brian M. Alexander(Brigham and Women's Hospital), Aaron R. Thorner(Center for Cancer Research), Ayal A. Aizer(Brigham and Women's Hospital), David A. Reardon(Dana-Farber Cancer Institute), Pankaj K. Agarwalla(Massachusetts General Hospital), Paul Van Hummelen, Ian F. Dunn(University of Oklahoma), Dora Dias‐Santagata(Harvard University)
Neuro-Oncology
January 28, 2016
Cited by 296


Related Papers